Glycine vs Magnesium
Both are commonly discussed for sleep and muscle & recovery. Glycine and Magnesium both have moderate evidence — Magnesium edges ahead on research volume (20 vs 20 studies referenced).
Evidence last reviewed May 2026
Glycine recommends stacking with Magnesium: Both glycine and magnesium are used to support sleep onset and quality; glycine may act via thermoregulatory mechanisms while magnesium influences NMDA receptor activity and relaxation.
Evidence
🟡Moderate Evidence
🟡Moderate Evidence
Research says
Research agrees
Research agrees
Expert mentions
176
3 recommend
315
4 recommend
Studies
20
referenced
20
referenced
Study dose
3000–15000mg
Sleep studies primarily used 3g (3000mg); the GlyNAC RCT and broader therapeutic reviews reference ranges up to 9–15g daily depending on the health outcome studied. Higher doses have been used in metabolic and aging contexts without notable adverse effects reported.
200–400mg
Studies and expert sources consistently reference 200–400 mg of elemental magnesium daily; the required capsule dose varies significantly by form, as elemental magnesium content differs — for example, magnesium glycinate is roughly 14% elemental magnesium, meaning a 400 mg capsule delivers only ~56 mg elemental magnesium.
Best timing
EveningEmpty stomach
EveningWith food
Who recommends
Caution
Generally safe
Generally safe
Glycine
Key findings
- ·A randomized clinical trial of GlyNAC (glycine + N-acetylcysteine) in older adults found improvements in glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and physical function, supporting glycine's role as a key substrate for glutathione synthesis.
- ·Glycine is a well-established biochemical precursor to glutathione, creatine, and collagen — three molecules with broad relevance to aging, muscle function, and tissue integrity.
- ·Glycine may be conditionally essential in older adults and under high physiological demand, as endogenous synthesis appears insufficient to meet total-body requirements in these contexts.
Evidence gaps
- ·Most clinical evidence for glycine uses combination products (e.g., GlyNAC, gelatin + vitamin C), making it impossible to determine how much of the observed benefit is attributable to glycine alone versus co-ingredients.
- ·Long-term supplementation trials in diverse human populations are lacking; existing studies are largely short-term and focused on older adults or athletes, leaving gaps for other demographics including those with chronic disease.
Magnesium
Key findings
- ·A strong-quality meta-analysis found oral magnesium supplementation improved sleep outcomes in older adults with insomnia, partially supporting claims about magnesium's role in sleep quality and onset.
- ·A strong-quality meta-analysis found magnesium supplementation positively affected glucose metabolism parameters in people with or at risk of type 2 diabetes, suggesting metabolic benefits in at-risk populations.
- ·Moderate-quality reviews support a role for magnesium in migraine prevention and in cardiovascular and cardiometabolic health, though causality and effect sizes require further confirmation.
Evidence gaps
- ·Most evidence comes from older adults or clinically deficient populations; it remains unclear whether magnesium supplementation benefits healthy individuals with adequate baseline magnesium levels.
- ·Form-specific clinical outcome data (e.g., glycinate, threonate, malate) is largely absent from high-quality trials, making it impossible to definitively recommend one form over another for specific outcomes like sleep or cognition.